Private company
Inotek
Pharmaceutical company based in Lexington, Massachusetts, United States, founded in 19961
Inotek Pharmaceuticals is a clinical-stage biopharmaceutical company based in Lexington, Massachusetts focused on the discovery, development and commercialization of novel therapies to treat glaucoma and other serious diseases of the eye. The Company's lead product candidate, trabodenoson (formerly known as INO-8875), is being evaluated for the treatment of elevated intraocular pressure associated with primary open-angle glaucoma (POAG) and ocular hypertension (OHT).2 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
- HeadquartersLexington1
- Websitewww.inotekpharma.com
See how the biggest companies compare on our leaderboards
Inotek Pharmaceuticals is a clinical-stage biopharmaceutical company based in Lexington, Massachusetts focused on the discovery, development and commercialization of novel therapies to treat glaucoma and other serious diseases of the eye.2
Timeline
- Jan 1, 1996Founded Founded1
Links
- Websitewww.inotekpharma.com1
- WikipediaInotek Pharmaceuticals
- WikidataQ6036654
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataInotek on Wikidata
- 2WikipediaInotek on Wikipedia